Showing 1 - 11 results of 11 for search 'Jason J. LeBlanc', query time: 0.04s Refine Results
  1. 1
    SARS-CoV-2 sensitivity limbo – How low can we go?

    SARS-CoV-2 sensitivity limbo – How low can we go? by Glenn Patriquin, Jason J. LeBlanc

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests

    Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests by Barbara L. Goodall, Jason J. LeBlanc, Todd F. Hatchette, Lisa Barrett, Glenn Patriquin

    Published 2022-08-01
    Get full text
    Article
  3. 3
    Evaluating the effectiveness of lockdowns and restrictions during SARS-CoV-2 variant waves in the Canadian province of Nova Scotia

    Evaluating the effectiveness of lockdowns and restrictions during SARS-CoV-2 variant waves in the Canadian province of Nova Scotia by Gustavo Sganzerla Martinez, Gustavo Sganzerla Martinez, Gustavo Sganzerla Martinez, Benjamin Hewins, Benjamin Hewins, Benjamin Hewins, Jason J. LeBlanc, Jason J. LeBlanc, Jason J. LeBlanc, Pacifique Ndishimye, Pacifique Ndishimye, Pacifique Ndishimye, Ali Toloue Ostadgavahi, Ali Toloue Ostadgavahi, Ali Toloue Ostadgavahi, David J. Kelvin, David J. Kelvin, David J. Kelvin

    Published 2023-04-01
    Get full text
    Article
  4. 4
    Using Serum Specimens for Real-Time PCR-Based Diagnosis of Human Granulocytic Anaplasmosis, Canada

    Using Serum Specimens for Real-Time PCR-Based Diagnosis of Human Granulocytic Anaplasmosis, Canada by Carl Boodman, Courtney Loomer, Antonia Dibernardo, Todd Hatchette, Jason J. LeBlanc, Brooks Waitt, L. Robbin Lindsay

    Published 2023-01-01
    Get full text
    Article
  5. 5
    Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer

    Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer by Jason J. LeBlanc, Gregory R. McCracken, Barbara Goodall, Todd F. Hatchette, Lisa Barrett, John Ross, Ross J. Davidson, Glenn Patriquin

    Published 2022-08-01
    Get full text
    Article
  6. 6
    Factors contributing to a coronavirus disease 2019 (COVID-19) outbreak on a mixed medical-surgical unit in a Canadian acute-care hospital

    Factors contributing to a coronavirus disease 2019 (COVID-19) outbreak on a mixed medical-surgical unit in a Canadian acute-care hospital by Megan K. McCallum, Glenn Patriquin, Ian R.C. Davis, Tammy MacDonald, Daniel Gaston, Jason J. LeBlanc, Yahya Shabi, B. Lynn Johnston

    Published 2022-01-01
    Get full text
    Article
  7. 7
    Neglected SARS-CoV-2 variants and potential concerns for molecular diagnostics: a framework for nucleic acid amplification test target site quality assurance

    Neglected SARS-CoV-2 variants and potential concerns for molecular diagnostics: a framework for nucleic acid amplification test target site quality assurance by Gregory R. McCracken, Daniel Gaston, Janice Pettipas, Allana Loder, Anna Majer, Elsie Grudeski, Geneviève Labbé, Bryn K. Joy, Glenn Patriquin, Jason J. LeBlanc

    Published 2023-12-01
    Get full text
    Article
  8. 8
    Real-world evaluation of the Lucira Check-It COVID-19 loop-mediated amplification (LAMP) test

    Real-world evaluation of the Lucira Check-It COVID-19 loop-mediated amplification (LAMP) test by Elizabeth Simms, Gregory R. McCracken, Todd F. Hatchette, Shelly A. McNeil, Ian Davis, Noella Whelan, Angela Keenan, Jason J. LeBlanc, Glenn Patriquin

    Published 2023-12-01
    Get full text
    Article
  9. 9
    Clinical features and outcomes of influenza and RSV coinfections: a report from Canadian immunization research network serious outcomes surveillance network

    Clinical features and outcomes of influenza and RSV coinfections: a report from Canadian immunization research network serious outcomes surveillance network by Henrique Pott, Jason J. LeBlanc, May S. ElSherif, Todd F. Hatchette, Shelly A. McNeil, Melissa K. Andrew, on behalf of the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)

    Published 2024-01-01
    Get full text
    Article
  10. 10
    Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada

    Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada by Ziyad O. Allehebi, Farhan M. Khan, Mark Robbins, Elizabeth Simms, Richard Xiang, Allam Shawwa, L. Robbin Lindsay, Antonia Dibernardo, Clarice d’Entremont, Alex Crowell, Jason J. LeBlanc, David J. Haldane

    Published 2022-06-01
    Get full text
    Article
  11. 11
    Generation of False-Positive SARS-CoV-2 Antigen Results with Testing Conditions outside Manufacturer Recommendations: A Scientific Approach to Pandemic Misinformation

    Generation of False-Positive SARS-CoV-2 Antigen Results with Testing Conditions outside Manufacturer Recommendations: A Scientific Approach to Pandemic Misinformation by Glenn Patriquin, Ross J. Davidson, Todd F. Hatchette, Breanne M. Head, Edgard Mejia, Michael G. Becker, Adrienne Meyers, Paul Sandstrom, Jacob Hatchette, Ava Block, Nicole Smith, John Ross, Jason J. LeBlanc

    Published 2021-10-01
    Get full text
    Article

Search Tools: